Chromatin control of environmental stress response
Lead Research Organisation:
University of Cambridge
Department Name: UNLISTED
Abstract
Our research will have two important implications. First, our work on toxicological effects of current therapeutics will provide molecular basis of 'side-effects' in patients. We focus on therapeutics in clinical trials targeting cellular protein-folding machinery in cancer cells. By understanding the unintended targets of these drugs in normal cells, our work will allow a better design of future drugs. Second, our work on environmental toxins will provide molecular framework for the bioassay and potential mitigation strategies to deal with toxic exposure. We focus on heavy metal toxins that are routinely found as industrial and natural contaminants in drinking water and food, affecting human as well as other animals and plants.
Technical Summary
Cells respond to environmental stress and toxins by mounting an adaptive stress response in order to survive stressful conditions. Transcriptional control is a major regulatory layer that determines the strength, the duration and persistence of cellular stress response. Transcription factors, chromatin modifications and non-coding RNA influence the transcriptional response to environmental stress. The molecular mechanisms by which chromatin exerts control over stress response is the main focus of the Unit programme. We aim to address the following questions:
(i) Which cellular pathways sense environmental stress/ toxins and signal to the genome?
(ii) How does chromatin interpret the information about cellular health and toxic exposure determining the transcriptional response to stress?
(iii) How does the transcriptional response adapt cellular phenotypes to survive the stress?
We study these three questions in the context of cellular exposure to environmental stress as well as small-molecule therapeutics in collaboration with pharmaceutical companies. Our approaches include genomics, single-cell transcriptomics, proteomics, chromatin biochemistry as well as genome-wide screening to identify novel components of stress-response pathways. Discovery-driven global approaches in mammalian cells are further validated by in vitro reconstitution experiments and mouse genetic models. We aim to gain novel insights and mechanistic understanding of transcriptional response to environmental toxins. In addition, our research will shed light on unintended toxicological effects of therapeutics. With the approach of understanding molecular basis of toxic effects, our research will suggest ways of mitigating with stress and toxicity.
(i) Which cellular pathways sense environmental stress/ toxins and signal to the genome?
(ii) How does chromatin interpret the information about cellular health and toxic exposure determining the transcriptional response to stress?
(iii) How does the transcriptional response adapt cellular phenotypes to survive the stress?
We study these three questions in the context of cellular exposure to environmental stress as well as small-molecule therapeutics in collaboration with pharmaceutical companies. Our approaches include genomics, single-cell transcriptomics, proteomics, chromatin biochemistry as well as genome-wide screening to identify novel components of stress-response pathways. Discovery-driven global approaches in mammalian cells are further validated by in vitro reconstitution experiments and mouse genetic models. We aim to gain novel insights and mechanistic understanding of transcriptional response to environmental toxins. In addition, our research will shed light on unintended toxicological effects of therapeutics. With the approach of understanding molecular basis of toxic effects, our research will suggest ways of mitigating with stress and toxicity.
Organisations
People |
ORCID iD |
Ritwick Sawarkar (Principal Investigator) |
Publications
Antonova A
(2019)
Heat-Shock Protein 90 Controls the Expression of Cell-Cycle Genes by Stabilizing Metazoan-Specific Host-Cell Factor HCFC1.
in Cell reports
Clapes T
(2021)
Chemotherapy-induced transposable elements activate MDA5 to enhance haematopoietic regeneration.
in Nature cell biology
Edkins AL
(2023)
Tenth International Symposium on the Hsp90 chaperone machine : Switzerland, October 19-23, 2022.
in Cell stress & chaperones
Kafkia E
(2022)
Operation of a TCA cycle subnetwork in the mammalian nucleus.
in Science advances
Lan C
(2023)
Quantitative real-time in-cell imaging reveals heterogeneous clusters of proteins prior to condensation.
in Nature communications
Leone S
(2024)
HSP70 binds to specific non-coding RNA and regulates human RNA polymerase III.
in Molecular cell
Mulroney TE
(2024)
N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting.
in Nature
Pittari D
(2022)
CREB3L1 and CREB3L2 control Golgi remodelling during decidualization of endometrial stromal cells.
in Frontiers in cell and developmental biology
Pérez-Cabello JA
(2023)
MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALS.
in Proceedings of the National Academy of Sciences of the United States of America
Rawat P
(2023)
SPTing across condensates: SEC-mediated translocation of SPT complex from pausing condensates to elongation condensates.
in EMBO reports
Related Projects
Project Reference | Relationship | Related To | Start | End | Award Value |
---|---|---|---|---|---|
MC_UU_00025/1 | 01/04/2018 | 31/07/2020 | £1,680,000 | ||
MC_UU_00025/2 | Transfer | MC_UU_00025/1 | 01/04/2018 | 30/09/2020 | £3,488,000 |
MC_UU_00025/3 | Transfer | MC_UU_00025/2 | 01/04/2018 | 31/03/2024 | £2,873,000 |
MC_UU_00025/4 | Transfer | MC_UU_00025/3 | 01/04/2018 | 31/03/2024 | £3,108,000 |
MC_UU_00025/5 | Transfer | MC_UU_00025/4 | 01/04/2018 | 31/03/2024 | £2,200,000 |
MC_UU_00025/6 | Transfer | MC_UU_00025/5 | 01/04/2018 | 31/05/2019 | £76,000 |
MC_UU_00025/7 | Transfer | MC_UU_00025/6 | 01/04/2018 | 31/03/2024 | £2,547,000 |
MC_UU_00025/8 | Transfer | MC_UU_00025/7 | 01/10/2019 | 31/03/2024 | £2,438,000 |
MC_UU_00025/9 | Transfer | MC_UU_00025/8 | 01/09/2019 | 31/03/2024 | £1,721,000 |
Description | ERC Consolidator Grant |
Amount | € 1,992,500 (EUR) |
Funding ID | 819753 - ChaperoneRegulome |
Organisation | European Commission |
Sector | Public |
Country | European Union (EU) |
Start | 01/2020 |
End | 12/2024 |
Description | Elucidating cellular mechanisms underlying adverse versus adaptive response to environmental chemicals |
Amount | £105,984 (GBP) |
Funding ID | BB/X511419/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2022 |
End | 09/2026 |
Description | TransNAT |
Amount | £8,000,000 (GBP) |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 12/2022 |
End | 11/2025 |
Description | iMed Postdosctoral fellowship |
Amount | € 140,000 (EUR) |
Organisation | AstraZeneca |
Sector | Private |
Country | United Kingdom |
Start | 04/2022 |
End | 03/2025 |